The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study
NCT ID: NCT05339477
Last Updated: 2025-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
4000 participants
OBSERVATIONAL
2022-04-26
2029-04-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The overall objective of the study is to explore associations between accelerometer measured physical activity and clinical outcomes after a myocardial infarction. Moreover, the association between changes in physical activity and outcomes will be assessed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Exercise SWEDEHEART Study
NCT04260958
Exercise Intervention in Patients With Heart Failure With Preserved and Reduced Ejection Fraction
NCT05255172
Effects of Personalized Training Program on Coronary Flow Reserve in Healthy Volunteers
NCT02713724
Implementation and Assessment of a Life-style Focused Patient Support Application in Myocardial Infarction Patients
NCT03260582
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
NCT04998877
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort group
Diagnosis of a type 1 myocardial infarction registered in SWEDEHEART Age 18-79 years at discharge from hospital
Accelerometer measurement
Study personnel will initiate an accelerometer and inform the patient to wear the accelerometer with an elastic belt on their right hip during waking hours for seven consecutive days. Moreover, patients are instructed to register their wear time in an activity diary in paper form. In addition, patients will register their working hours, if relevant. After seven days, patients send back the accelerometer and diary in a pre-paid envelope. The same procedure is repeated at the second follow-up visit at 1 year.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Accelerometer measurement
Study personnel will initiate an accelerometer and inform the patient to wear the accelerometer with an elastic belt on their right hip during waking hours for seven consecutive days. Moreover, patients are instructed to register their wear time in an activity diary in paper form. In addition, patients will register their working hours, if relevant. After seven days, patients send back the accelerometer and diary in a pre-paid envelope. The same procedure is repeated at the second follow-up visit at 1 year.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of a type 1 myocardial infarction registered in SWEDEHEART
* Age 18-79 years at discharge from hospital
* Attending the first visit in the cardiac rehabilitation (CR) registry SEPHIA (2 months after discharge)
Exclusion Criteria
* Non-ambulatory
* Any mental condition that may interfere with the possibility for the patient to comply with the study protocol
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Bäck
Professor, physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Bäck, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of physiotherapy, Sahlgrenska University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alingsås lasarett
Alingsås, , Sweden
NU-sjukvården Dalslands sjukhus
Bäckefors, , Sweden
Bollnäs sjukhus
Bollnäs, , Sweden
Höglandssjukhuset Eksjö
Eksjö, , Sweden
Lasarettet Enköping
Enköping, , Sweden
Gävle sjukhus
Gävle, , Sweden
Sahlgrenska University Hospital Sahlgrenska
Gothenburg, , Sweden
Helsingborgs lasarett
Helsingborg, , Sweden
Jönköping Ryhov Hospital
Jönköping, , Sweden
Kalix sjukhus
Kalix, , Sweden
Länssjukhuset Kalmar
Kalmar, , Sweden
Centralsjukhuset Karlstad
Karlstad, , Sweden
Kullbergska sjukhuset
Katrineholm, , Sweden
Västmanlands sjukhus Köping
Köping, , Sweden
Universitetssjukhuset Linköping
Linköping, , Sweden
Sunderby sjukhus
Luleå, , Sweden
NU-sjukvården Lysekil
Lysekil, , Sweden
Skåne Universitetssjukhus Malmö
Malmo, , Sweden
Vrinnevisjukhuset
Norrköping, , Sweden
Oskarshamns sjukhus
Oskarshamn, , Sweden
Västmanlands sjukhus Sala
Sala, , Sweden
Sandvikens sjukhus
Sandviken, , Sweden
Capio Närsjukhus Simrishamn
Simrishamn, , Sweden
Skaraborgs sjukhus Skövde
Skövde, , Sweden
Söderhamns sjukhus
Söderhamn, , Sweden
Capio St Göran
Stockholm, , Sweden
Karolinska University Hospital Solna and Huddinge
Stockholm, , Sweden
Södersjukhuset
Stockholm, , Sweden
NU-sjukvården Strömstad
Strömstad, , Sweden
Norrlands Universitetssjukhus Umeå
Umeå, , Sweden
Akademiska sjukhuset
Uppsala, , Sweden
Hallands sjukhus Varberg
Varberg, , Sweden
Värnamo sjukhus
Värnamo, , Sweden
Västerviks sjukhus
Västervik, , Sweden
Visby Lasarett
Visby, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Petter Tollemark
Role: primary
Maria Östman
Role: primary
Helene Warin
Role: primary
Görel Stengård
Role: primary
Anna Cutler
Role: primary
Bjarne Madsen Härdig
Role: primary
Magdalena Engren Jonsson
Role: primary
Charlotta Lans
Role: primary
Karin Arinell
Role: primary
Hanna Hafström Eng
Role: primary
Marianne Ordell Schieman
Role: primary
Sabina Borg
Role: primary
Maarit Kylmamaa
Role: primary
Marica Stenström
Role: primary
Margret Leosdottir
Role: primary
Sofi Karlsson
Role: primary
Marica Hallsten Larsson
Role: primary
Anna Cutler
Role: primary
Pernilla Rosberg Håkansson
Role: primary
Frida Brevitz
Role: primary
Anna-Sara Raphael
Role: primary
Anneli Johansson
Role: primary
Robin Hofmann
Role: primary
Barbro Limnell
Role: primary
Emil Hagström
Role: primary
Frida Johansson
Role: primary
Monica Cederblad
Role: primary
Emmy Cheruiyot Johansson
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
277371
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.